Diagnostic Pathology is an open access, peer-reviewed, online journal that considers research in surgical and clinical pathology, immunology, and biology, with a special focus on cutting-edge approaches in diagnostic pathology and tissue-based therapy. Read more here.
Aims and Scope
Top reviewers of 2018
We recognize that our peer reviewers play a pivotal role in maintaining the standard of the journal by critically evaluating our submissions. The editors and staff of Diagnostic Pathology thank our reviewers for their valuable time and efforts. As a token of our appreciation, we would like to publicly recognize the top peer reviewers of 2018.
Jamshid Abdul-Ghafar, French Medical Institute for Mothers and Children, Afghanistan
Yoko Matsuda, Tokyo Metropolitan Geriatric Hospital, Japan
Maria Raffaella Ambrosio, University of Siena, Italy
Shikha Saini, University of Illinois at Chicago, USA
Li Bian, University of Colorado, USA
Genevieve Crane, Weill Cornell Medicine, USA
Joon Hyuk Choi, Yeungnam University School of Medicine, South Korea
Ahmet Aydogan, Cukurova University, Turkey
Vicente Marco Molina, Hospital Quirónsalud Barcelona, Spain
Marius Lund-Iversen, Universitetet i Oslo, Norway
Georgios Deftereos, University of Utah, USA
Call for papers - Precision Oncology
We are pleased to announce a new cross-journal thematic series on ‘Precision Oncology’ across a number of BMC journals within the oncology portfolio to help bring together the latest research on precision oncology.
The thematic series is now open for submission of original research and review articles - for further information about this series please click here.
Dr Anil Parwani, Editor-in-Chief
"Diagnostic Pathology has emerged as a premier journal that aims to publish cutting edge articles focused on diagnostic pathology with an emphasis on novel morphological and molecular findings that make an impact on diagnosis of neoplastic and non-neoplastic diseases. The goal of the editorial board and our team is to highlight the cross-roads of diagnostic pathology and new tools and technologies that are exciting, challenging and making an impact on the practice of pathology. We will continue to bring updates in the field of diagnostic pathology by way of novel and interesting case reports, research and original articles and a series of key review articles by experts in the field that will emphasize the new developments which are disease-specific and highlight contemporary and novel technologies that are changing the practice of diagnostic pathology. This is an exciting time in pathology as we are confronted with a new frontier of science and technology which continues to evolve and accelerate the discipline of diagnostic pathology and we wish to take our readers with us on this exciting journey. We want to collaborate with our reviewers and our readers to make Diagnostic Pathology a premier and trusted source of new and exciting developments in the field of diagnostic pathology."
Dr Anil Parwani, Ohio State University
Annual Journal Metrics
59 days to first decision for reviewed manuscripts only
49 days to first decision for all manuscripts
121 days from submission to acceptance
16 days from acceptance to publication
139 Altmetric Mentions